Medistim ASA (DE:MD1) has released an update.
Medistim ASA set a new quarterly sales record at MNOK 144.9, marking a 5.5% increase from last year, and achieved a 4.5% sales growth in the first half of the year. The company maintains a strong recurring sales rate and reports a solid cash position with no long-term debt. A dividend of NOK 4.50 per share was paid in May, as Medistim continues to show robust financial health.
For further insights into DE:MD1 stock, check out TipRanks’ Stock Analysis page.